Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Genetica Medica, Rome, Italy.
Istituto di Medicina Genomica, Università Cattolica del Sacro Cuore, Rome, Italy.
Fam Cancer. 2019 Oct;18(4):421-427. doi: 10.1007/s10689-019-00139-3.
Muir-Torre syndrome (MTS) is clinically characterized by the occurrence of skin, usually sebaceous, and visceral tumors in the same individual. The most common underlying mechanism is a constitutional defect of the mismatch repair (MMR) genes that cause Lynch syndrome (LS). Herewithin we report on a 76 years-old male patient heterozygous for a pathogenic MSH2 missense substitution who presented with a striking cutaneous phenotype in the absence of typical LS visceral tumors. The patient developed 20 skin tumors, including sebaceous adenomas/carcinomas and keratoacanthomas. Two skin tumors showed immunohistochemical loss of MSH2 and MSH6 expression. There was no apparent family history of neoplasia. Based on the variable involvement of the skin and internal organs, we suggest that the definition of tumor associations that are often observed as variants of inherited tumor syndromes, such as MTS, should be guided by the underlying molecular bases. In addition, the presence of multiple sebaceous tumors, especially if showing MMR deficiency, appears to be a very strong indicator of a constitutional MMR gene defect. The reasons underlying the high phenotypic variability of cutaneous phenotypes associated with constitutional MMR defects are yet to be determined.
穆尔- Torre 综合征(MTS)的临床特征是同一患者中发生皮肤(通常为皮脂腺)和内脏肿瘤。最常见的潜在机制是错配修复(MMR)基因的结构缺陷,导致 Lynch 综合征(LS)。在此,我们报告了一名 76 岁男性患者,其 MSH2 错义取代为杂合子,该患者在没有典型 LS 内脏肿瘤的情况下表现出明显的皮肤表型。该患者发生了 20 个皮肤肿瘤,包括皮脂腺腺瘤/癌和角化棘皮瘤。两个皮肤肿瘤表现出 MSH2 和 MSH6 表达的免疫组化缺失。没有明显的家族肿瘤病史。基于皮肤和内部器官的不同受累,我们建议,通常作为遗传肿瘤综合征(如 MTS)变体观察到的肿瘤关联的定义,应基于潜在的分子基础。此外,多发性皮脂腺肿瘤的存在,特别是如果表现出 MMR 缺陷,似乎是结构 MMR 基因缺陷的一个非常强的指标。与结构 MMR 缺陷相关的皮肤表型高度表型变异性的原因尚待确定。